Skip to main content

Month: April 2024

Eramet: Adjusted turnover of €761m in Q1 2024

Paris, 25 April 2024, 7:00 a.m. PRESS RELEASE Eramet: Adjusted turnover of €761m in Q1 2024Adjusted turnover1 of €761m (-19%) reflecting, as expected, a strong negative price effect (-24%), while the positive volume effect is limited (+2%), penalised by the decline in SLN volumes soldGood operational performance of the Group’s main mining activities compared to the unfavourable comparison base of Q1 2023:+27% in manganese ore volumes sold from Gabon +52% in nickel ore volumes produced in Indonesia, but -17% in volumes sold, reflecting the absence of sales of low-grade saprolites over the quarter, whose commercialization permit for 2024 is under assessment by the Indonesian government +52% in zircon volumes and +36% in ilmenite2 sold from SenegalStrong decline in selling prices compared to Q1 2023Neutralization of SLN’s...

Continue reading

Dassault Systèmes Reports Solid First Quarter Results And Reaffirms Full-Year Objectives

Press Release VELIZY-VILLACOUBLAY, France — April 25, 2024 Dassault Systèmes Reports Solid First Quarter Results And Reaffirms Full-Year Objectives Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced IFRS unaudited estimated financial results for the first quarter ended March 31, 2024. The Group’s Board of Directors approved these estimated results on April 24, 2024. This press release also includes financial information on a non-IFRS basis and reconciliations with IFRS figures in the Appendix. Summary Highlights (unaudited, IFRS & non-IFRS unless otherwise noted, all revenue growth rates in constant currencies)1Q24: Software revenue increased 7%, aligned with objectives, and services revenue grew 2%, resulting in total revenue up 6%; 1Q24: Combining the revenue growth from upfront licenses and subscription,...

Continue reading

SPIE – Press release – Quarterly information as at March 31st, 2024

Cergy, April 25th, 2024 Q1 2024 revenue up +11.6%, confirming our unique positioning on dynamic markets overall and reflecting our outstanding delivery on our bolt-on M&A strategyStrong +6.2% organic growth including a very high contribution from The Netherlands, Austria, Poland and Global Services Energy, a good level of organic growth in Germany at +4.1% and France remaining very solid at +2.2% +5.1% contribution from bolt-on acquisitions +0.3% from currency movements Positive dynamics on our markets overall with a good visibility for the yearOutstanding M&A activity supported by a rich pipeline of opportunities in our geographiesClosing of the acquisition of Correll group (Global Services Energy) in January 2024 and ROBUR in March 2024 (Germany) In Q1 2024 SPIE announced the acquisition of:ICG in Germany in City Networks...

Continue reading

Equinor first quarter 2024 results

Equinor (OSE: EQNR, NYSE: EQNR) delivered adjusted operating income* of USD 7.53 billion and USD 2.57 billion after tax in the first quarter of 2024. Equinor reported net operating income of USD 7.63 billion and net income at USD 2.67 billion. Adjusted net income* was USD 2.84 billion, leading to adjusted earnings per share* of USD 0.96. Financial and operational performanceStrong operational performance and production Solid financial results and cash flow High results from marketing and tradingStrategic progressPower-from-shore to the Sleipner and Gudrun fields on NCS Empire Wind 1 awarded new offtake agreement Announced high-grading of US onshore gas positionCapital distributionFirst quarter ordinary cash dividend of USD 0.35 per share Continued extraordinary cash dividend of USD 0.35 per share and second tranche of share buy-back...

Continue reading

Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab

SHANGHAI, China, April 24, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug Office, Department of Health, the Government of the Hong Kong Special Administrative Region (“DO”) has recently accepted the New Drug Application (“NDA”) for toripalimab in combination with cisplatin and gemcitabine for the first-line treatment of adults with metastatic or recurrent locally advanced nasopharyngeal carcinoma (“NPC”), and as a single agent for the treatment of adults with recurrent, unresectable, or metastatic NPC with disease progression on or after platinum-containing chemotherapy. The NDA is supported by results from...

Continue reading

Marex Group plc Announces Pricing of Initial Public Offering

NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) — Marex Group plc (“Marex”), the diversified global financial services platform, today announces the pricing of its initial public offering (the “IPO”), at $19.00 per share. A total of 15,384,615 ordinary shares are being offered, of which 3,846,153 shares are being offered by Marex and 11,538,462 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Marex will not receive any proceeds from any sale of shares by the Selling Shareholders. The ordinary shares are expected to begin trading on the Nasdaq Global Select Market on April 25, 2024, under the ticker symbol “MRX.” The offering is expected to close on April 29, 2024, subject to customary closing conditions. In connection with the offering, the Selling Shareholders have granted the underwriters a 30-day...

Continue reading

Asante Announces Correction to Press Release

VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) — Asante Gold Corporation (“Asante” or the “Company” CSE:ASE | GSE:ASG | FRANKFURT:1A9 | U.S.OTC:ASGOF) announces a correction to the voting numbers and percentages included in its press release announcing the results of its annual general meeting of shareholders (the “Meeting“) held yesterday, April 23, 2024. The press release provided voting results from proxies received and did not include ballot results at the Meeting. The Company confirms that all matters presented for approval by management were duly authorized and approved. Corrected detailed voting results of the Meeting are as follows: Detailed Voting Results:Resolution Votes For Votes Against Votes WithheldFixing the Number of Directors at Nine 276,119,224(95.77%) 12,186,877(4.23%) NilAppointment...

Continue reading

TransAlta Declares Dividends

CALGARY, Alberta, April 24, 2024 (GLOBE NEWSWIRE) — The Board of Directors of TransAlta Corporation (TSX: TA) (NYSE: TAC) declared a quarterly dividend of $0.06 per common share payable on July 1, 2024 to shareholders of record at the close of business on June 1, 2024. The Board of Directors also declared the following quarterly dividend on its Cumulative Redeemable Rate Reset First Preferred Shares for the period starting from and including March 31, 2024, up to but excluding June 30, 2024:Preferred Shares TSX Stock Symbol Dividend Rate Dividend Per Share RecordDate PaymentDateSeries A TA.PR.D 2.877% $0.17981 June 1, 2024 June 30, 2024Series B* TA.PR.E 7.011% $0.43579 June 1, 2024 June 30, 2024Series C TA.PR.F 5.854% $0.36588 June 1, 2024 June 30, 2024Series D* TA.PR.G 8.081% $0.50230 June 1, 2024 June 30, 2024Series...

Continue reading

Net Income of R$ 55.3 mm in 1Q24, a 90.1% Increase YOY and Leases EBITDA Margin of 72.1%

On track to deliver 2024 Record Production of 500,000 sqm of GLA BELO HORIZONTE, Brazil, April 24, 2024 (GLOBE NEWSWIRE) — Log Commercial Properties (B3: LOGG3), a leading developer of greenfield assets and lessor of Class A logistics warehouses in Brazil, is pleased to announce its financial results for the first quarter. 1Q24 Operational Highlights:Deliveries totaling 57,000 sqm of GLA were completed with a 100% pre-lease rate Milestone of 2.0 million sqm of GLA historically delivered by the Company Gross absorption of 134,000 sqm of GLA Stabilized vacancy of 0.91%, Same Client Rent of 1,9%, above inflation for the 7th consecutive quarter1Q24 Financial Highlights:Strong EBITDA of R$ 74.0 million in 1Q24, with a growth of 36.4% EBITDA from leases of R$ 38.8 million and a margin of 72.1% in 1Q24 Asset recycling of R$ 1.7...

Continue reading

Quorum Announces Q4 and Year End 2023 Results

Adjusted EBITDA¹ up 26% to $7.0 Million for 2023 CALGARY, Alberta, April 24, 2024 (GLOBE NEWSWIRE) — Quorum Information Technologies Inc. (TSX-V: QIS) (OTC Pink: QIFTF) (“Quorum”), a North American SaaS Software and Services company providing essential enterprise solutions that automotive dealerships and Original Equipment Manufacturers (“OEMs”) rely on for their operations, released its results today for the fourth quarter and fiscal year ended December 31, 2023. Financial references are expressed in Canadian dollars unless otherwise indicated. Please refer to the MD&A and Financial Statements posted onto SEDAR related to non-IFRS measures and risk factors. “Throughout 2023, Quorum focused on a more profitable growth strategy which emphasized cross-selling and better company-wide cost management,” stated Maury Marks, President...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.